We are the combination of four hospitals: the General Hospital, the Children’s Hospital, the Women’s Hospital and the Traumatology, Rehabilitation and Burns Hospital. We are part of the Vall d’Hebron Barcelona Hospital Campus: a world-leading health park where healthcare plays a crucial role.
Patients are the centre and the core of our system. We are professionals committed to quality care and our organizational structure breaks down the traditional boundaries between departments and professional groups, with an exclusive model of knowledge areas.
Would you like to know what your stay at Vall d'Hebron will be like? Here you will find all the information.
The commitment of Vall d'Hebron University Hospital to innovation allows us to be at the forefront of medicine, providing first class care adapted to the changing needs of each patient.
Researchers of the Stroke Research group and the Arrhytmia Unit.
Atrial fibrillation alert in a smartwatch.
Patient with a smartwatch.
Smartwatches are a practical, low-cost, noninvasive method that helps in the early detection of atrial fibrillations in some patients, which increase the risk of recurrent stroke.
One in every six people will have a stroke in their lifetime. With the aging of the population, this frequency is expected to increase in the coming years, and it is necessary to develop new strategies to improve the prevention of new cases. A study led by Vall d'Hebron has analyzed the use of smartwatches for early detection of atrial fibrillation, the most common type of arrhythmia, which increases the risk of stroke by up to five times. The results, published in Sensors, show that they could be a useful complementary tool to medical care in the follow-up of hospitalized patients after a stroke to prevent recurrence. The work has been led by Dr. Jorge Pagola, researcher of the Stroke Research Group of Vall d'Hebron Research Institute (VHIR) and adjunct of the Stroke Unit of the Vall d'Hebron University Hospital together with the Arrhythmia Unit and in collaboration with the Joan XXIII University Hospital and the University Hospital of Girona Dr. Josep Trueta.
The study was carried out with 70 patients from the Vall d'Hebron Hospital aged 80 years on average and hospitalized for having recently suffered a stroke. All of them wore a Fitbit smartwatch to measure heart rate and, in addition, a continuous electrocardiogram was performed for a few hours. The aim was to compare the results obtained with both strategies when detecting atrial fibrillation, which are associated with a higher probability of suffering a stroke and, moreover, of it being more severe and disabling. "The watches represent a simple-to-use, low-cost, non-invasive and well-accepted strategy that could be useful for monitoring patients, also in elderly people", explains Dr. Claudia Meza, member of the Stroke Unit of Vall d'Hebron Hospital and researcher of the Stroke Research Group at VHIR.
On the one hand, heart rate was measured in hospitalized patients, and it was observed that the watch tended to underestimate the real values, especially when they were higher than 100 beats per minute or when there was an episode of arrhythmia. It is thought that the changes in the skin and blood circulation present in advanced age may alter the measurement and, therefore, the watches would not be recommended for monitoring heart rate in these patients.
On the other hand, the researchers analyzed the watch alerts that appear when it detects that there is an irregular heart rhythm, suggestive of atrial fibrillation. It was found that the watch was capable of detecting 34.5% of real cases of this arrhythmia, with a specificity of 100%. In other words, it detected one third of the cases, but all of them actually had atrial fibrillation according to the electrocardiogram.
Based on the results, smartwatches can help track some stroke patients over the long term, especially those with intermittent episodes of arrhythmias and no clear associated symptoms, which can be difficult to detect without continuous monitoring. "It is important to emphasize that they should be a tool to help the usual diagnostic methods for detecting arrhythmias. In no case should they replace regular medical care, as we must then confirm the results obtained and adjust treatment accordingly if necessary to prevent subsequent strokes", emphasizes Dr. Jorge Pagola.
In the future, more research is needed to evaluate the effectiveness of these methods in clinical practice, both in younger people and in patients who are not hospitalized while going about their daily lives. In addition, it is expected that continued technological development will also increase the sensitivity to detect a higher percentage of cases.
The study has received funding from the Instituto de Salud Carlos III and co-financed by the European Union (ERDF/ESF) - A way to build Europe ((PI2001210), as well as the eHealth Center of the Universitat Oberta de Catalunya (UOC).
"It is important to emphasize that they should be a tool to help the usual diagnostic methods for detecting arrhythmias. In no case should they replace regular medical care", emphasizes Dr. Jorge Pagola.
Strokes and Cerebral Haemodynamics, General Hospital
The acceptance of these terms implies that you give your consent to the processing of your personal data for the provision of the services you request through this portal and, if applicable, to carry out the necessary procedures with the administrations or public entities involved in the processing. You may exercise the mentioned rights by writing to web@vallhebron.cat, clearly indicating in the subject line “Exercise of LOPD rights”. Responsible entity: Vall d’Hebron University Hospital (Catalan Institute of Health). Purpose: Subscription to the Vall d’Hebron Barcelona Hospital Campus newsletter, where you will receive news, activities, and relevant information. Legal basis: Consent of the data subject. Data sharing: If applicable, with VHIR. No other data transfers are foreseen. No international transfer of personal data is foreseen. Rights: Access, rectification, deletion, and data portability, as well as restriction and objection to its processing. The user may revoke their consent at any time. Source: The data subject. Additional information: Additional information can be found at https://hospital.vallhebron.com/es/politica-de-proteccion-de-datos.